Russell L. Skibsted
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Russell L. Skibsted
Russell L. Skibsted is recorded as CFO at Processa Pharmaceuticals, Inc. (PCSA). Processa Pharmaceuticals, Inc. reported in an 8-K filed July 17, 2024 that Russell L. Skibsted was appointed Chief Financial Officer (CFO), effective July 17, 2024.
“Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (Processa or the Company), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs with improved efficacy and safety, announces the appointment of Russell L. Skibsted as Chief Financial Officer (CFO), effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-07-17–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Processa Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- George Ng CEO, Board Member
- Russell Skibsted CFO
- David Young Board Member
- Geraldine Pannu Board Member
- James Neal Board Member
- James R. Neal Board Member
- Justin Yorke Board Member
- Khoso Baluch Board Member
- Sheila Gujrathi Board Member
- Virgil Thompson Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.